These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34098299)

  • 1. Low-barrier buprenorphine during the COVID-19 pandemic: A rapid transition to on-demand telemedicine with wide-ranging effects.
    Buchheit BM; Wheelock H; Lee A; Brandt K; Gregg J
    J Subst Abuse Treat; 2021 Dec; 131():108444. PubMed ID: 34098299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A qualitative study of patient experiences with telemedicine opioid use disorder treatment during COVID-19.
    Lockard R; Priest KC; Gregg J; Buchheit BM
    Subst Abus; 2022; 43(1):1150-1157. PubMed ID: 35499402
    [No Abstract]   [Full Text] [Related]  

  • 3. Low Threshold Telemedicine-based Opioid Treatment for Criminal Justice Involved Adults During the COVID-19 Pandemic: A Case Report.
    Flavin L; Tofighi B; Krawczyk N; Schatz D; McNeely J; Butner J
    J Addict Med; 2022 Jan-Feb 01; 16(1):e59-e61. PubMed ID: 35120069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telehealth for opioid use disorder treatment in low-barrier clinic settings: an exploration of clinician and staff perspectives.
    Aronowitz SV; Engel-Rebitzer E; Dolan A; Oyekanmi K; Mandell D; Meisel Z; South E; Lowenstein M
    Harm Reduct J; 2021 Nov; 18(1):119. PubMed ID: 34823538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Barrier Tele-Buprenorphine in the Time of COVID-19: A Case Report.
    Harris M; Johnson S; Mackin S; Saitz R; Walley AY; Taylor JL
    J Addict Med; 2020; 14(4):e136-e138. PubMed ID: 32433364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-Threshold Buprenorphine via Community Partnerships and Telemedicine-Case Reports of Expanding Access to Addiction Treatment During COVID-19.
    Levander XA; Wheelock H; Pope J; Lee A; Hartmann K; Abuelkhair S; Gregg JL; Buchheit BM
    J Addict Med; 2022 Jan-Feb 01; 16(1):e56-e58. PubMed ID: 34374502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptation of a System of Treatment for Substance Use Disorders During the COVID-19 Pandemic.
    Komaromy M; Tomanovich M; Taylor JL; Ruiz-Mercado G; Kimmel SD; Bagley SM; Saia KM; Costello E; Park TW; LaBelle C; Weinstein Z; Walley AY
    J Addict Med; 2021 Nov-Dec 01; 15(6):448-451. PubMed ID: 33298750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of COVID-19 Telehealth Policy Changes on Buprenorphine Treatment for Opioid Use Disorder.
    Lin LA; Zhang L; Kim HM; Frost MC
    Am J Psychiatry; 2022 Oct; 179(10):740-747. PubMed ID: 35899380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing a low-threshold audio-only telehealth model for medication-assisted treatment of opioid use disorder at a community-based non-profit organization in Washington, D.C.
    Yeo EJ; Kralles H; Sternberg D; McCullough D; Nadanasabesan A; Mayo R; Akselrod H; Catalanotti J
    Harm Reduct J; 2021 Dec; 18(1):127. PubMed ID: 34886850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilizing telemedicine during COVID-19 pandemic for a low-threshold, street-based buprenorphine program.
    Harris R; Rosecrans A; Zoltick M; Willman C; Saxton R; Cotterell M; Bell J; Blackwell I; Page KR
    Drug Alcohol Depend; 2022 Jan; 230():109187. PubMed ID: 34890927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What Was the Change in Telehealth Usage and Proportion of No-show Visits for an Orthopaedic Trauma Clinic During the COVID-19 Pandemic?
    Siow MY; Walker JT; Britt E; Kozy JP; Zanzucchi A; Girard PJ; Schwartz AK; Kent WT
    Clin Orthop Relat Res; 2020 Oct; 478(10):2257-2263. PubMed ID: 32639309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid Transition to Telehealth and the Digital Divide: Implications for Primary Care Access and Equity in a Post-COVID Era.
    Chang JE; Lai AY; Gupta A; Nguyen AM; Berry CA; Shelley DR
    Milbank Q; 2021 Jun; 99(2):340-368. PubMed ID: 34075622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs.
    Lambdin BH; Kan D; Kral AH
    Subst Abuse Treat Prev Policy; 2022 Jul; 17(1):51. PubMed ID: 35841036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder.
    Weintraub E; Seneviratne C; Anane J; Coble K; Magidson J; Kattakuzhy S; Greenblatt A; Welsh C; Pappas A; Ross TL; Belcher AM
    JAMA Netw Open; 2021 Aug; 4(8):e2118487. PubMed ID: 34448869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The perspective of Canadian health care professionals on abortion service during the COVID-19 pandemic.
    Ennis M; Wahl K; Jeong D; Knight K; Renner R; Munro S; Dunn S; Guilbert E; Norman WV
    Fam Pract; 2021 Aug; 38(Suppl 1):i30-i36. PubMed ID: 34448482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine.
    Uscher-Pines L; Sousa J; Raja P; Mehrotra A; Barnett M; Huskamp HA
    J Subst Abuse Treat; 2020 Nov; 118():108124. PubMed ID: 32893047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19: A catalyst for change in telehealth service delivery for opioid use disorder management.
    Mehtani NJ; Ristau JT; Snyder H; Surlyn C; Eveland J; Smith-Bernardin S; Knight KR
    Subst Abus; 2021; 42(2):205-212. PubMed ID: 33684331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion of a Traditional In-Person Feeding Clinic to a Telehealth-Only Model of Care.
    Fleet SE; Davidson RD; Carr K; Lubenow C; Rouse AS; Truscott KE
    Matern Child Health J; 2022 Jan; 26(1):58-64. PubMed ID: 34978018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An examination of telehealth policy impacts on initial rural opioid use disorder treatment patterns during the COVID-19 pandemic.
    Hughes PM; Verrastro G; Fusco CW; Wilson CG; Ostrach B
    J Rural Health; 2021 Jun; 37(3):467-472. PubMed ID: 33720447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic.
    Wang L; Weiss J; Ryan EB; Waldman J; Rubin S; Griffin JL
    J Subst Abuse Treat; 2021 May; 124():108272. PubMed ID: 33771276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.